Conditions: Atopic Dermatitis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 56
Healthy volunteers: no

Brief summary:
A multi-center, open-label, Phase IV, unblinded study using Cutivate (fluticasone propionate, 0.05%)lotion and it's possible effects on the HPA axis of infants diagnosed with atopic dermatitis.

Detailed description:

Arms:
arm 1: Receive between 22 and 29 days of Cutivate lotion treatment

Interventions: intervention 1: Fluticasone propionate 0.05% lotion
Intervention descriptions: intervention 1: Daily applications

Protocol document: